There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Frontiers Genetically Modified T Cells for Esophageal Cancer
Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy - ScienceDirect
New Gastric & Esophageal Cancer Treatment Breakthrough
Esophageal Cancer, MUSC Health
The Next Breakthrough Against Cancer?, Features
Recent advances in immune therapies for gastric cancer
New Cancer Treatment: The Hope of Cancer Free World On Its way
Esophageal cancer risk could be reduced by esomeprazole and low
Advancements and challenges in oncolytic virus therapy for
2022: WEO Webinar: Endoscopic treatment for early gastric cancer
Esophageal Cancer Action Network - Esophageal Cancer Action Network
Gastric cancer treatment: recent progress and future perspectives, Journal of Hematology & Oncology
Gastric Cancer Foundation In breakthrough, Japanese researchers
Cancers, Free Full-Text
Zanidatamab, With Biparatopic Binding to HER2, Shows 84% OS in